Interferons and cancer therapy.
A variety of human interferons, alpha, beta and gamma are now recognised. Three types of alpha-interferon have been submitted to clinical assessment. Overall, the results have been disappointing. Attention is now directed towards their use in combination with conventional cytotoxic agents.
D000818:Animals; D002648:Child; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D010212:Papilloma / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000628:therapy; D014412:Tumor Virus Infections / Q000628:therapy
D007370:Interferon Type I